Unapproved Drugs Add to Intrathecal Pump Risk
Intrathecal pumps, drug-delivery systems that have been controversial in workers’ compensation, are the subject of a warning issued Thursday by the U.S. Food and Drug Administration. The FDA has cautioned…
Member Spotlight: City of Oakland Manages a Catastrophic Claim using Paradigm
Catastrophic and complex injuries are uncommon, but when they occur, they are costly in so many ways! The employer wants to find their employee the best possible care to get…
Paradigm Outcomes Q&A: Talking Expansion with the Case Management Firm’s CEO
The work comp community has been abuzz with some action involving Paradigm Outcomes. 1) Adva-Net was acquired by the firm, as published here. Adva-Net specializes in pain management, post-acute care…
Rousmaniere: Should We Declare War on Brain Injury?
The more we learn about brain injury, the more we find we need to learn—and act. The scope of the brain injury problem in America, even after what has been…
New naloxone provides more opioid overdose options
Pharmacy and healthcare experts cautiously praised the planned development of a fast-acting, better version of naloxone (Narcan), which is used to reverse the effects of opioid overdoses. The US Department…
Paradigm Deal Illustrates Interest in Catastrophic Care
Paradigm Outcomes, a provider of medical management for catastrophically injured workers, has entered into an agreement to be acquired by OMERS Private Equity, the companies announced Thursday. Terms of the…
RiverGlade Capital Welcomes Jim Hudak and Dan Skowronski
RiverGlade Capital ("RiverGlade"), is pleased to announce that Jim Hudak has been engaged as an Operating Partner and will have an exclusive relationship with the firm. As an Operating Partner,…